Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries plans to achieve net profits after tax worth EGP 129 million during fiscal year (FY) 2021/2022, compared to the EGP 208 million that was approved for the current FY.
The targeted amount is yet higher that the recorded net profits worth EGP 116.99 million in FY20/21, according to a bourse disclosure on Wednesday.
Alexandria Pharmaceuticals aims to generate revenues worth EGP 1.22 billion in FY21/22, less than the EGP 1.44 billion approved for the current fiscal year. The company had achieved revenues standing at EGP 1.11 billion in FY20/21.
